• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Porto-Pulmonary Syndrome

October 1, 2020 By Dr. Jeremy Feldman

Portopulmonary hypertension

An important cause of PAH is liver disease.  Up to 5% of patients with cirrhosis (scarring in the liver) or portal hypertension (high pressure in the blood vessels of the liver) can develop PAH.  All causes of cirrhosis and portal hypertension can develop PAH.   Causes The most common causes of cirrhosis (scarring of the liver that leads to … [Read more...]

Pulmonary Hypertension Due To Valvular Heart Disease

October 29, 2019 By Dr. Jeremy Feldman

heart valves in pulmonary hypertension

As a quick refresher, remember that Pulmonary Hypertension is broadly divided into five groups: Group 1:  Pulmonary Arterial Hypertension Group 2:  PH due to left heart disease and valvular heart disease Group 3:  PH due to chronic lung disease (pulmonary fibrosis or emphysema) Group 4:  PH due to chronic blood clots Group 5:  PH due to various miscellaneous … [Read more...]

Scleroderma: Screening for Pulmonary Hypertension

October 10, 2019 By Dr. Jeremy Feldman

PAH Physician

Co-Authored By: Dr. Akshay Muralidhar Scleroderma is part of a special group of diseases called connective tissue diseases.  This group of diseases includes lupus, rheumatoid arthritis, mixed connective tissue disease and many others.  A key feature of these diseases is that the disease may involve multiple parts of their body including skin, joints, … [Read more...]

Pulmonary Hypertension and Methamphetamines

June 14, 2019 By Dr. Jeremy Feldman

stimulant drugs associated with pulmonary arterial hypertension

Although the opioid epidemic is attracting more attention, there is another epidemic in America, methamphetamine abuse.  Methamphetamine (Meth) is an inexpensive drug that can be smoked, snorted or injected. It is made in a chemical reaction involving a common cold medicine.  Most Meth, however, is imported from Mexico.  Meth is extremely … [Read more...]

Do I or Don’t I Have PAH?

May 9, 2019 By Dr. Jeremy Feldman

Internal anatomy of the pulmonary arteries

We had a wonderful topic suggestion from a reader. Essentially, how does one tell if they have Pulmonary Arterial Hypertension if there are conflicting tests? A common scenario goes something like this: The echocardiogram shows no pulmonary hypertension but a CT scan shows pulmonary hypertension.  A cardiologist repeats an echo that shows no pulmonary … [Read more...]

Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Massachusetts Pulmonary Hypertension Task Force

Massachusetts – First State to Create PAH Task Force

By Dr. Jeremy Feldman

  The first PAH State Task Force has been created in Massachusetts. The purpose of the force is to monitor

Internal anatomy of the pulmonary arteries

Echocardiography and Pulmonary Arterial Hypertension: A Detailed Look

By Dr. Jeremy Feldman

An echocardiogram (or echo) is an ultrasound-based test that can tell us a great deal about your heart.  By bouncing and

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives